Development of Market Access Strategy
Aston Health has sufficient resources and experience to offer its clients the turnkey solutions for market access and pricing assessments:
- Conducting HTA analysis using own resources and in collaboration with the leading pharmacoeconomic institutions in this country
- Generating research information from Patient Registers in more than 20 disease areas
- Identifying regional potential in reimbursement segment: cross-analysis of sales data (based on public tenders) and prescribing volumes (based on registry data) – Aston 360
- Pricing studies
- Developing Market Access Strategies on federal and regional levels
- Tracking changes in the Russian healthcare system – PharmCompass Россия and PharmCompass Регионы
In recent years, the Russian pharmaceutical market has been undergoing significant changes, especially with respect to public regulation and funding, which had a significant impact on market entry strategies.
Market Access and HTA are playing an increasing role in the commercial success of marketed drugs, medical devices and equipment in the region-specific environment.
This requires industry players to focus on obtaining proper and timely insights on regulatory and funding changes at federal and regional level.
![Aleksandr Ivanov Aleksandr Ivanov](upload/images/ask/a.ivanov.png)
Aleksandr Ivanov
Head of Strategic Consulting Department